58 results on '"Riekkinen P"'
Search Results
2. Pulse-echo ultrasound method for detection of post-menopausal women with osteoporotic BMD
3. Prediction of hip osteoporosis by DXA using a novel pulse-echo ultrasound device
4. Pharmacomechanical Thrombectomy in Paget–Schroetter Syndrome
5. New method for point-of-care osteoporosis screening and diagnostics
6. Multi-site bone ultrasound measurements in elderly women with and without previous hip fractures
7. The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients
8. THA disrupts mismatch negativity in Alzheimer disease
9. Effects of stimulation of alpha1-adrenergic and NMDA/glycine-B receptors on learning defects in aged rats
10. Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior
11. Effects of ZK 93426 on muscarinic and nicotinic antagonist or nucleus basalis lesioning-induced electrocortical slowing
12. Comparative effects of alpha-2 receptor agents and THA on the performance of adult and aged rats in the delayed non-matching to position task
13. The effects of alpha-2 adrenoceptor antagonist, atipamezole, on spatial learning in scopolamine-treated and aged rats
14. The effects of alaproclate and p-chlorophenylalanine on cued navigation performance in rats
15. Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate
16. Maturity and growth rate effects on Scots pine basic density
17. Moderate cortical EEG changes in apolipoprotein E-deficient mice during ageing and scopolamine treatment but not after nucleus basalis lesion
18. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue
19. Oxotremorine suppresses thalamocortical oscillations via thalamic muscarinic acetylcholine receptors
20. Pitfalls in the quantitative estimation of β-amyloid immunoreactivity in human brain tissue
21. Activation of acetylcholine receptors and 5-HT2 receptors have additive effects in the suppression of neocortical high-voltage spindles in aged rats
22. Relationship between EEG reactivity and neuropsychological tests in vascular dementia
23. Additive deficits in the choice accuracy of rats in the delayed non-matching to position task after cholinolytics and serotonergic lesions are non-mnemonic in nature
24. Chronic nimodipine and acute metrifonate treatment decreases age-related cortical high voltage spindles in rats
25. The systemic administration of tacrine or selegiline facilitate spatial learning in aged fisher 344 rats
26. Cognitive Adverse Effects of Antiepileptic Drugs: Incidence, Mechanisms and Therapeutic Implications
27. Diagnostic accuracy of alzheimer’s disease: A neuropathological study
28. The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats
29. Regional cerebral blood flow measured by99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease
30. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions
31. Tetrahydroaminoacridine inhibits high voltage spindle activity in aged rats after acute and chronic treatment
32. A long-term follow-up study of cerebrospinal fluid acetylcholinesterase in delirium
33. Testing for mutations in exon 17 of the β-amyloid precursor protein gene in Finnish Alzheimer patients and normal subjects
34. Place of Newer Antiepileptic Drugs in the Treatment of Epilepsy
35. Circulating immune complexes in sera from patients with Alzheimer's disease and subjects with age-associated memory impairment
36. The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease
37. The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats
38. Cognitive and memory deficits in untreated Parkinson's disease and amyotrophic lateral sclerosis patients: A comparative study
39. Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies
40. Cognitive profile of Alzheimer patients with extrapyramidal signs: A longitudinal study
41. Extrapyramidal signs in Alzheimer's disease: A 3-year follow-up study
42. Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls
43. The molecular forms of acetylcholinesterase in cerebrospinal fluid of normal subjects — effect of aging
44. Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus
45. Neurotransmitter markers in the cerebrospinal fluid of normal subjects effects of aging and other confounding factors
46. Cholinesterase activities in the autonomic nervous system of rabbits with experimental allergic neuritis: A biochemical study
47. Effects of L-tryptophan treatment on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis
48. Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease
49. Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data
50. Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.